Description: The 3rd Annual Interlaken Leadership Awards (sponsored by CSL Behring) support investigator-led research into neuroimmunology and novel uses for polyvalent immunoglobulins.
dmd (256) nmo (23) ivig (18) duchenne muscular dystrophy (17) intravenous immunoglobulin (5) csl behring (4) neuromyelitis optica (4) interlaken leadership awards (3) polyvalent immunoglobulin therapy (3) plasma protein biotherapeutics (3)
CSL Behring is pleased to welcome you to the Interlaken Leadership Awards program , a global initiative to support investigator-led research in the field of polyvalent immunoglobulin therapy.
The Interlaken Leadership Awards support original research in the field of neuroimmunology. Investigators whose proposals are approved by the review committee will receive monetary grants and/or drug supply. In order to accommodate a wide variety of investigator needs, the size of the individual grants are not predetermined. However small innovative trials and pilot studies may be favoured over large confirmatory trials.
The deadline for submitting letters of intent for this review cycle has passed. Full applications for the 2017 Interlaken Leadership Awards will be accepted through April 30, 2018 by invitation only. Please see the Application process.